Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.

Nakamura A, Tajima K, Zolzaya K, Sato K, Inoue R, Yoneda M, Fujita K, Nozaki Y, Kubota KC, Haga H, Kubota N, Nagashima Y, Nakajima A, Maeda S, Kadowaki T, Terauchi Y.

Diabetologia. 2012 Dec;55(12):3382-91. doi: 10.1007/s00125-012-2703-1. Epub 2012 Sep 7.

PMID:
22955994
[PubMed - indexed for MEDLINE]
2.

Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.

Asano T, Watanabe K, Kubota N, Gunji T, Omata M, Kadowaki T, Ohnishi S.

J Gastroenterol Hepatol. 2009 Oct;24(10):1669-76. doi: 10.1111/j.1440-1746.2009.06039.x.

PMID:
19788607
[PubMed - indexed for MEDLINE]
3.

Lessons from mouse models of high-fat diet-induced NAFLD.

Nakamura A, Terauchi Y.

Int J Mol Sci. 2013 Oct 24;14(11):21240-57. doi: 10.3390/ijms141121240. Review.

PMID:
24284392
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.

Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW, Gorrell MD, Yue DK, Twigg SM.

J Hepatol. 2011 Aug;55(2):435-44. doi: 10.1016/j.jhep.2010.10.039. Epub 2010 Dec 22.

PMID:
21184785
[PubMed - indexed for MEDLINE]
5.

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G.

Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G825-34. doi: 10.1152/ajpgi.00145.2011. Epub 2011 Aug 11.

PMID:
21836057
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.

Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ.

Hepatology. 2010 Sep;52(3):934-44. doi: 10.1002/hep.23797.

PMID:
20607689
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.

Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC.

J Gastroenterol Hepatol. 2009 Oct;24(10):1658-68. doi: 10.1111/j.1440-1746.2009.05996.x.

PMID:
19788606
[PubMed - indexed for MEDLINE]
8.

Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene.

Soga M, Hashimoto S, Kishimoto Y, Hirasawa T, Makino S, Inagaki S.

Exp Anim. 2010;59(4):407-19.

PMID:
20660987
[PubMed - indexed for MEDLINE]
Free Article
9.

Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.

Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.

Gastroenterology. 2007 Jan;132(1):282-93. Epub 2006 Oct 12.

PMID:
17241878
[PubMed - indexed for MEDLINE]
10.

Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.

Wang C, Cui Y, Li C, Zhang Y, Xu S, Li X, Li H, Zhang X.

Lipids Health Dis. 2013 Nov 4;12:165. doi: 10.1186/1476-511X-12-165.

PMID:
24188280
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
[PubMed - indexed for MEDLINE]
12.

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.

Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X.

Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.

PMID:
21985374
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.

Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.

Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.

PMID:
18794597
[PubMed - indexed for MEDLINE]
14.

Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.

Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, Mori S, Tokuyama K, Kubota N, Kadowaki T, Terauchi Y.

Metabolism. 2011 May;60(5):617-28. doi: 10.1016/j.metabol.2010.06.008. Epub 2010 Aug 2.

PMID:
20673929
[PubMed - indexed for MEDLINE]
15.

A mouse model for nonalcoholic steatohepatitis.

Sundaresan S, Vijayagopal P, Mills N, Imrhan V, Prasad C.

J Nutr Biochem. 2011 Oct;22(10):979-84. doi: 10.1016/j.jnutbio.2010.08.011. Epub 2010 Dec 28.

PMID:
21190824
[PubMed - indexed for MEDLINE]
16.

The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.

Cong WN, Tao RY, Tian JY, Liu GT, Ye F.

Life Sci. 2008 May 7;82(19-20):983-90. doi: 10.1016/j.lfs.2008.01.022. Epub 2008 Mar 4.

PMID:
18417155
[PubMed - indexed for MEDLINE]
17.

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.

Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN.

Hepatology. 2013 Jan;57(1):81-92. doi: 10.1002/hep.25789.

PMID:
22508243
[PubMed - indexed for MEDLINE]
18.

DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.

Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F.

J Hepatol. 2011 Dec;55(6):1391-9. doi: 10.1016/j.jhep.2011.02.035. Epub 2011 Apr 13.

PMID:
21703208
[PubMed - indexed for MEDLINE]
19.

Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T.

J Clin Invest. 2007 Jan;117(1):246-57.

PMID:
17200721
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation.

Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N.

J Nutr. 2010 Nov;140(11):1915-22. doi: 10.3945/jn.110.125732. Epub 2010 Sep 22.

PMID:
20861209
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk